BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9788200)

  • 41. Review of evidence for loss of motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome.
    Engel AG
    Ann N Y Acad Sci; 1991; 635():246-58. PubMed ID: 1660237
    [No Abstract]   [Full Text] [Related]  

  • 42. Lambert Eaton myasthenic syndrome.
    Petty R
    Pract Neurol; 2007 Aug; 7(4):265-7. PubMed ID: 17636143
    [No Abstract]   [Full Text] [Related]  

  • 43. The Lambert-Eaton syndrome.
    Smith RG; Appel SH
    Hosp Pract (Off Ed); 1992 Dec; 27(12):101-6, 111-3, 116. PubMed ID: 1333470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome.
    Sher E; Comola M; Nemni R; Canal N; Clementi F
    Lancet; 1990 Feb; 335(8686):413. PubMed ID: 1968140
    [No Abstract]   [Full Text] [Related]  

  • 45. Calcium channel types at the neuromuscular junction.
    Wray D; Porter V
    Ann N Y Acad Sci; 1993 Jun; 681():356-67. PubMed ID: 8395150
    [No Abstract]   [Full Text] [Related]  

  • 46. Linear B-cell epitopes in Lambert-Eaton myasthenic syndrome defined by cell-free synthetic peptide binding.
    Parsons KT; Kwok WW
    J Neuroimmunol; 2002 May; 126(1-2):190-5. PubMed ID: 12020970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrophysiological differences in seropositive and seronegative Lambert-Eaton myasthenic syndrome.
    Oh SJ; Hatanaka Y; Claussen GC; Sher E
    Muscle Nerve; 2007 Feb; 35(2):178-83. PubMed ID: 17058271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory action of Lambert-Eaton syndrome IgG on calcium currents in a thyroid C-cell line.
    Kim YI; Blandino JK; O'Shaughnessy TJ
    Ann N Y Acad Sci; 1993 Jun; 681():398-401. PubMed ID: 8395154
    [No Abstract]   [Full Text] [Related]  

  • 49. Neuronal proteins and paraneoplastic syndromes.
    Kornguth SE
    N Engl J Med; 1989 Dec; 321(23):1607-8. PubMed ID: 2586557
    [No Abstract]   [Full Text] [Related]  

  • 50. [Paraneoplastic neurologic syndrome--neoplasms and neuroimmune system].
    Inuzuka T; Tanaka K
    Nihon Naika Gakkai Zasshi; 1998 Jun; 87(6):1138-43. PubMed ID: 9702029
    [No Abstract]   [Full Text] [Related]  

  • 51. [Lambert-Eaton syndrome].
    Osterhage J; Jost WH; Schimrigk K
    Med Klin (Munich); 1996 Aug; 91(8):526-30. PubMed ID: 8965753
    [No Abstract]   [Full Text] [Related]  

  • 52. Lambert-Eaton syndrome IgG inhibits dihydropyridine-sensitive, slowly inactivating calcium channels in bovine adrenal chromaffin cells.
    Blandino JK; Kim YI
    Ann N Y Acad Sci; 1993 Jun; 681():394-7. PubMed ID: 8395153
    [No Abstract]   [Full Text] [Related]  

  • 53. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction.
    Pellkofer HL; Voltz R; Kuempfel T
    Muscle Nerve; 2009 Aug; 40(2):305-8. PubMed ID: 19609921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of P/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome.
    Fukuda T; Motomura M; Nakao Y; Shiraishi H; Yoshimura T; Iwanaga K; Tsujihata M; Eguchi K
    Ann Neurol; 2003 Jan; 53(1):21-8. PubMed ID: 12509844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lambert-Eaton myasthenic syndrome.
    Mareska M; Gutmann L
    Semin Neurol; 2004 Jun; 24(2):149-53. PubMed ID: 15257511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SOX1 autoantibodies: tumor markers in LEMS patients?
    Lang B; Evoli A
    Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
    [No Abstract]   [Full Text] [Related]  

  • 58. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
    Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
    J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The mechanism of neurotransmitter release: role of synaphin/complexin in synaptic vesicle exocytosis].
    Abe T
    Tanpakushitsu Kakusan Koso; 2002 Jun; 47(7):794-800. PubMed ID: 12058476
    [No Abstract]   [Full Text] [Related]  

  • 60. An autoimmune animal model of the Lambert-Eaton syndrome.
    Kim YI; Middlekauff EH; Viglione MP; Okutsu J; Satoh Y; Hirashima N; Kirino Y
    Ann N Y Acad Sci; 1998 May; 841():670-6. PubMed ID: 9668312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.